Too many men ignore symptoms until they can no longer function. We end up seeing them in the emergency room, sometimes with late-stage cancer or uncontrolled chronic disease that could have been managed if addressed earlier. The post Rethinking Masculinity in Men’s Health appeared first on MedCity News.
Virtual visits have demonstrated solid potential to expand access, reduce in‑office congestion, and support continuity of care, but implementing these tools successfully relies on careful planning and strategy. The post Five Key Considerations for Integrating Virtual Care into Your Practice appeared first on MedCity News.
AI is no panacea, but it can have a role in turning artisanal, trial-and-error drug development into a rapid, cost-effective, data-driven process. The post AI Meets Gene Editing: the Path to Plug-and-Play Drug Development appeared first on MedCity News.
We’re getting close to the July 19 deadline for submissions. Don’t miss this opportunity to pitch your company to a team of investors at INVEST Digital Health in Dallas on September 18! The post Is Your AI-Driven Healthcare Startup Ready for New Investment? Apply to INVEST Digital Health Pitch Perfect Today. appeared first on MedCity…
[Sponsored] CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients’ blood pressure, operating in a similar way to continuous glucose monitors. Watch or…
Verona Pharma bring to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product in COPD alone, its potential extends to other respiratory disorders as well. The post Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to…
For hospitals and health systems, the challenge is steep, but so is the opportunity. TEAM offers a framework to deliver more coordinated, cost-effective, and patient-focused care. Those who prepare now will be far better positioned to thrive in a value-based future. The post Mandatory by 2026: 5 Ways to Prepare for CMS’ TEAM Payment Model…
GLP-1s are a breakthrough, but they are not the end of the story. To ensure lasting success, we must pair pharmacological interventions with behavioral support, personalized data, and continuous guidance. The post Beyond the Prescription: Supporting Long-Term Metabolic Health After GLP-1s appeared first on MedCity News.
[Sponsored] At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch. The post The Human Algorithm: What AI Can’t Replace in Pharma Engagement appeared first on MedCity News.
Samsung announced plans to acquire Xealth, a startup that helps hospitals integrate digital tools into clinical workflows, as part of its broader push into U.S. healthcare. The deal reflects growing provider demand for tech solutions and comes amid newfound optimism in the digital health exit market. The post Samsung Deepens Healthcare Bet With Xealth Acquisition…